Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced injectables.

Hims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a spot that discusses obesity

A multi-million dollar Super Bowl ad from telehealth company Hims and Hers downplays risks and side effects of compounded weight loss drugs.

Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the heart of the ongoing GLP-1 phenomenon.

There’s an obesity epidemic and we feel we can bring a ton of awareness to people through the Super Bowl,” said Dan Kenger, chief design officer at Hims & Hers. “There are very few live TV events that we as America all come around and congregate for and this provides a good platform to get that message out there.

Telehealth company's spot decries medications from others as "priced for profits, not patients," while its own weight-loss drugs are "affordable."